Tata Motors, SBI Life, Dr. Reddy’s Q2 results in focus

Investors awaited Q2 results from Tata Motors, SBI Life, and Dr. Reddy’s, signaling focus on auto, banking, and pharma earnings resilience.

neutral
Recently

Tata Motors, SBI Life, Dr. Reddy’s Q2 results in focus

1 min read68 words
No Image
Investors awaited Q2 results from Tata Motors, SBI Life, and Dr.
Investors turned focus to Q2FY26 earnings from Tata Motors, SBI Life, SBI Cards, and Dr. Reddy’s Laboratories on October 24. Tata Motors tracked electric vehicle sales expectations, while PSU banks gained 0.4% pre-market amid dividend hopes. The broader market eyed sector-specific performance as the Q2 earnings season neared its end. Analysts forecast stable auto demand, resilient insurance inflows, and moderate pharma margins, reflecting steady fundamentals despite global headwinds.
Oct 24, 2025 • 03:57
Sentinel